Marelise E.
- Country
- The Netherlands
- Department
- Endocrinology
Research Overview
- Phase 3 Randomized, Placebo-Controlled Trial Evaluating Garetosmab Efficacy and Safety in Adult Patients with Fibrodysplasia Ossificans Progressiva
- Efficacy and Safety Evaluation of INCB000928 in Fibrodysplasia Ossificans Progressiva: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Teriparatide and Zoledronic Acid in the Management of Osteogenesis Imperfecta: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 2 of 11 partner sites.
Specializations
Rare Bone Disorders
Specializes in the investigation of Fibrodysplasia Ossificans Progressiva (FOP), a rare genetic condition characterized by abnormal bone formation in soft tissues. The investigator focuses on evaluating novel therapeutic approaches for managing progressive heterotopic ossification (HO).
- Progressive bone formation disorders
- Genetic bone conditions
- Soft tissue calcification
Conducts research into advanced imaging techniques including whole body computed tomography for monitoring disease progression.
Therapeutic Innovation
Explores multiple therapeutic pathways through the evaluation of various investigational compounds targeting abnormal bone formation. The research encompasses both oral and intravenous treatment modalities for rare bone disorders.
- Novel therapeutic compounds
- Treatment optimization
- Drug safety assessment
Investigates the potential of bone-targeted therapies in managing progressive ossification conditions.
Clinical Management
Focuses on the development of comprehensive treatment approaches for bone disorders, including Osteogenesis Imperfecta. Investigates combination therapies involving parathyroid hormone and bone-strengthening medications.
- Fracture prevention
- Bone density management
- Treatment protocols
Studies preventive strategies and therapeutic interventions for rare skeletal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.